THEMISMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Themis Medicare Ltd is disclosing that, following Board approval on 13th February 2026, it had applied to BSE and NSE for in-principle approval of a preferential allotment of convertible warrants. The Stock Exchanges raised queries and observations on the application. In response, the company obtained a Valuation Report from an Independent Registered Valuer and an updated Compliance Certificate from a Practicing Company Secretary, both now hosted on the company's website. The company is filing this disclosure in compliance with SEBI LODR Regulation 30.
This is a routine compliance filing confirming proper procedures are being followed for a proposed preferential allotment. The involvement of an independent valuer and updated compliance certificate suggests governance diligence, but there is no immediate impact on stock fundamentals from this filing alone.